nodes	percent_of_prediction	percent_of_DWPC	metapath
Paramethadione—CYP2E1—Parkinson's disease	0.829	1	CbGaD
Paramethadione—Trimethadione—CYP2E1—Parkinson's disease	0.00718	1	CrCbGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000411	0.0025	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—DLG4—Parkinson's disease	0.000403	0.00245	CbGpPWpGaD
Paramethadione—CYP3A4—Estrogen metabolism—COMT—Parkinson's disease	0.000402	0.00245	CbGpPWpGaD
Paramethadione—CYP3A4—Tryptophan metabolism—DDC—Parkinson's disease	0.0004	0.00244	CbGpPWpGaD
Paramethadione—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—Parkinson's disease	0.000396	0.00241	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—GRIN2B—Parkinson's disease	0.000394	0.0024	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—DLG4—Parkinson's disease	0.00039	0.00237	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—DLG4—Parkinson's disease	0.00039	0.00237	CbGpPWpGaD
Paramethadione—CACNA1H—Corticotropin-releasing hormone—MAPK8—Parkinson's disease	0.000385	0.00234	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—GRIN2B—Parkinson's disease	0.000381	0.00232	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—GRIN2B—Parkinson's disease	0.000381	0.00232	CbGpPWpGaD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000377	0.00229	CbGpPWpGaD
Paramethadione—CYP2C8—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000372	0.00226	CbGpPWpGaD
Paramethadione—CYP3A4—Estrogen metabolism—GSTM1—Parkinson's disease	0.000367	0.00224	CbGpPWpGaD
Paramethadione—CYP2C9—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000362	0.0022	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000354	0.00215	CbGpPWpGaD
Paramethadione—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000345	0.0021	CbGpPWpGaD
Paramethadione—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000345	0.0021	CbGpPWpGaD
Paramethadione—CYP2C8—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.00034	0.00207	CbGpPWpGaD
Paramethadione—CYP3A4—Tryptophan metabolism—MAOB—Parkinson's disease	0.000337	0.00205	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000335	0.00204	CbGpPWpGaD
Paramethadione—CACNA1G—NCAM signaling for neurite out-growth—IL6—Parkinson's disease	0.000323	0.00197	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—ABL1—Parkinson's disease	0.000321	0.00195	CbGpPWpGaD
Paramethadione—CACNA1H—NCAM signaling for neurite out-growth—IL6—Parkinson's disease	0.000313	0.0019	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—ABL1—Parkinson's disease	0.000311	0.00189	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—ABL1—Parkinson's disease	0.000311	0.00189	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000307	0.00187	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—HSPA8—Parkinson's disease	0.000306	0.00186	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000306	0.00186	CbGpPWpGaD
Paramethadione—CYP2C9—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.000303	0.00184	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—HSPA8—Parkinson's disease	0.000297	0.00181	CbGpPWpGaD
Paramethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—Parkinson's disease	0.000292	0.00177	CbGpPWpGaD
Paramethadione—CYP2C8—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.00029	0.00176	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—DLG4—Parkinson's disease	0.000287	0.00175	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—GSTA4—Parkinson's disease	0.000284	0.00173	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—GRIN2B—Parkinson's disease	0.000281	0.00171	CbGpPWpGaD
Paramethadione—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000281	0.00171	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00028	0.0017	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00028	0.0017	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—DLG4—Parkinson's disease	0.000278	0.00169	CbGpPWpGaD
Paramethadione—CYP2C9—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000277	0.00169	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—GRIN2B—Parkinson's disease	0.000272	0.00166	CbGpPWpGaD
Paramethadione—CYP2E1—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000266	0.00162	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—MAOB—Parkinson's disease	0.000253	0.00154	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000249	0.00151	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—GSTA4—Parkinson's disease	0.000245	0.00149	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000242	0.00147	CbGpPWpGaD
Paramethadione—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—Parkinson's disease	0.000239	0.00145	CbGpPWpGaD
Paramethadione—CYP2C9—Arachidonic acid metabolism—GPX1—Parkinson's disease	0.000236	0.00143	CbGpPWpGaD
Paramethadione—CYP2C8—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.00023	0.0014	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—ABL1—Parkinson's disease	0.000229	0.00139	CbGpPWpGaD
Paramethadione—CYP3A4—Tryptophan metabolism—CYP2E1—Parkinson's disease	0.000229	0.00139	CbGpPWpGaD
Paramethadione—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—Parkinson's disease	0.000228	0.00139	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000227	0.00138	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—ABL1—Parkinson's disease	0.000222	0.00135	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—MAOB—Parkinson's disease	0.000221	0.00134	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—MAOB—Parkinson's disease	0.000218	0.00133	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—INS—Parkinson's disease	0.000205	0.00125	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2D6—Parkinson's disease	0.000202	0.00123	CbGpPWpGaD
Paramethadione—CYP3A4—Oxidation by Cytochrome P450—CYP2D6—Parkinson's disease	0.0002	0.00122	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—GSTA4—Parkinson's disease	0.000199	0.00121	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000197	0.0012	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—CYP2D6—Parkinson's disease	0.000188	0.00114	CbGpPWpGaD
Paramethadione—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000187	0.00114	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.000185	0.00113	CbGpPWpGaD
Paramethadione—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000185	0.00113	CbGpPWpGaD
Paramethadione—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000183	0.00111	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—MAOB—Parkinson's disease	0.000178	0.00108	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000164	0.000999	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP2D6—Parkinson's disease	0.000162	0.000988	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00016	0.000975	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—INS—Parkinson's disease	0.000151	0.000921	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.00015	0.000913	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—CYP2E1—Parkinson's disease	0.000148	0.000904	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—INS—Parkinson's disease	0.000147	0.000892	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000146	0.000891	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—COMT—Parkinson's disease	0.000142	0.000866	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—GSTP1—Parkinson's disease	0.000142	0.000862	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—MAOA—Parkinson's disease	0.000141	0.00086	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—COMT—Parkinson's disease	0.00014	0.000855	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—GSTP1—Parkinson's disease	0.00014	0.00085	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.000136	0.000826	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP2D6—Parkinson's disease	0.000132	0.000804	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000132	0.000801	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00013	0.000793	CbGpPWpGaD
Paramethadione—CYP2E1—Biological oxidations—GSTM1—Parkinson's disease	0.00013	0.000792	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.00013	0.00079	CbGpPWpGaD
Paramethadione—CYP2E1—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000128	0.000782	CbGpPWpGaD
Paramethadione—CACNA1I—Axon guidance—IL6—Parkinson's disease	0.000126	0.000765	CbGpPWpGaD
Paramethadione—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000123	0.000751	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—COMT—Parkinson's disease	0.000123	0.000749	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—GSTP1—Parkinson's disease	0.000122	0.000745	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—MAOA—Parkinson's disease	0.000122	0.000744	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—COMT—Parkinson's disease	0.000121	0.000739	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—CYP2E1—Parkinson's disease	0.000121	0.000736	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000121	0.000735	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000119	0.000725	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000117	0.000714	CbGpPWpGaD
Paramethadione—CYP2C8—Biological oxidations—GSTM1—Parkinson's disease	0.000113	0.000685	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—TNF—Parkinson's disease	0.000111	0.000676	CbGpPWpGaD
Paramethadione—CYP2C8—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000111	0.000676	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—GBA—Parkinson's disease	0.00011	0.000673	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—COMT—Parkinson's disease	0.0001	0.00061	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—GSTP1—Parkinson's disease	9.97e-05	0.000607	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—MAOA—Parkinson's disease	9.94e-05	0.000605	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—COMT—Parkinson's disease	9.88e-05	0.000601	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—GSTP1—Parkinson's disease	9.83e-05	0.000598	CbGpPWpGaD
Paramethadione—CACNA1G—Axon guidance—IL6—Parkinson's disease	9.26e-05	0.000564	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—ND3—Parkinson's disease	9.23e-05	0.000562	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—MCCC1—Parkinson's disease	9.23e-05	0.000562	CbGpPWpGaD
Paramethadione—CYP2C9—Biological oxidations—GSTM1—Parkinson's disease	9.16e-05	0.000557	CbGpPWpGaD
Paramethadione—CYP2C9—Metapathway biotransformation—GSTM1—Parkinson's disease	9.03e-05	0.00055	CbGpPWpGaD
Paramethadione—CACNA1H—Axon guidance—IL6—Parkinson's disease	8.97e-05	0.000546	CbGpPWpGaD
Paramethadione—CACNA1I—Developmental Biology—IL6—Parkinson's disease	8.97e-05	0.000546	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	8.71e-05	0.00053	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—TALDO1—Parkinson's disease	8.68e-05	0.000528	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—OMD—Parkinson's disease	8.68e-05	0.000528	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	8.59e-05	0.000523	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	8.47e-05	0.000516	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—NDUFB11—Parkinson's disease	8.23e-05	0.000501	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—TNF—Parkinson's disease	8.19e-05	0.000499	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—ND3—Parkinson's disease	7.98e-05	0.000486	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—MCCC1—Parkinson's disease	7.98e-05	0.000486	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	7.97e-05	0.000485	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—TNF—Parkinson's disease	7.93e-05	0.000483	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.86e-05	0.000478	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GCH1—Parkinson's disease	7.85e-05	0.000478	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—OMD—Parkinson's disease	7.5e-05	0.000457	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—TALDO1—Parkinson's disease	7.5e-05	0.000457	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—NDUFB11—Parkinson's disease	7.11e-05	0.000433	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—DBH—Parkinson's disease	7e-05	0.000426	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—FBP1—Parkinson's disease	7e-05	0.000426	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GBA—Parkinson's disease	7e-05	0.000426	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G6—Parkinson's disease	6.9e-05	0.00042	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GCH1—Parkinson's disease	6.78e-05	0.000413	CbGpPWpGaD
Paramethadione—CACNA1G—Developmental Biology—IL6—Parkinson's disease	6.61e-05	0.000402	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—COMT—Parkinson's disease	6.6e-05	0.000402	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	6.57e-05	0.0004	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	6.56e-05	0.000399	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	6.51e-05	0.000396	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—ND3—Parkinson's disease	6.49e-05	0.000395	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—MCCC1—Parkinson's disease	6.49e-05	0.000395	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	6.48e-05	0.000395	CbGpPWpGaD
Paramethadione—CACNA1H—Developmental Biology—IL6—Parkinson's disease	6.4e-05	0.00039	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	6.12e-05	0.000372	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—TALDO1—Parkinson's disease	6.11e-05	0.000372	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—OMD—Parkinson's disease	6.11e-05	0.000372	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—DBH—Parkinson's disease	6.05e-05	0.000368	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GBA—Parkinson's disease	6.05e-05	0.000368	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—FBP1—Parkinson's disease	6.05e-05	0.000368	CbGpPWpGaD
Paramethadione—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	6.04e-05	0.000368	CbGpPWpGaD
Paramethadione—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	5.96e-05	0.000363	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—NDUFB11—Parkinson's disease	5.79e-05	0.000352	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GCH1—Parkinson's disease	5.52e-05	0.000336	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—DDC—Parkinson's disease	5.13e-05	0.000313	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—Parkinson's disease	4.98e-05	0.000303	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GBA—Parkinson's disease	4.92e-05	0.0003	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—FBP1—Parkinson's disease	4.92e-05	0.0003	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—DBH—Parkinson's disease	4.92e-05	0.0003	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GSTA4—Parkinson's disease	4.85e-05	0.000295	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—DDC—Parkinson's disease	4.44e-05	0.00027	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—PLA2G6—Parkinson's disease	4.37e-05	0.000266	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—MAOB—Parkinson's disease	4.32e-05	0.000263	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.28e-05	0.000261	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—ND3—Parkinson's disease	4.28e-05	0.000261	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GSTA4—Parkinson's disease	4.19e-05	0.000255	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	4.14e-05	0.000252	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—OMD—Parkinson's disease	4.03e-05	0.000245	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—TALDO1—Parkinson's disease	4.03e-05	0.000245	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.82e-05	0.000232	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—PLA2G6—Parkinson's disease	3.77e-05	0.00023	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—MAOB—Parkinson's disease	3.74e-05	0.000227	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.64e-05	0.000222	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—DDC—Parkinson's disease	3.61e-05	0.00022	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	3.56e-05	0.000216	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GSTA4—Parkinson's disease	3.41e-05	0.000208	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—Parkinson's disease	3.37e-05	0.000205	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.25e-05	0.000198	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—DBH—Parkinson's disease	3.25e-05	0.000198	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GBA—Parkinson's disease	3.25e-05	0.000198	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYP2D6—Parkinson's disease	3.21e-05	0.000196	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CTGF—Parkinson's disease	3.15e-05	0.000192	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—PLA2G6—Parkinson's disease	3.07e-05	0.000187	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—MAOB—Parkinson's disease	3.04e-05	0.000185	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—NQO1—Parkinson's disease	2.9e-05	0.000177	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism of lipids and lipoproteins—APOE—Parkinson's disease	2.89e-05	0.000176	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—TH—Parkinson's disease	2.86e-05	0.000174	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP2D6—Parkinson's disease	2.78e-05	0.000169	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—CYCS—Parkinson's disease	2.75e-05	0.000167	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CTGF—Parkinson's disease	2.73e-05	0.000166	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYP2E1—Parkinson's disease	2.54e-05	0.000155	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—NQO1—Parkinson's disease	2.51e-05	0.000153	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—TH—Parkinson's disease	2.47e-05	0.000151	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—COMT—Parkinson's disease	2.43e-05	0.000148	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GSTP1—Parkinson's disease	2.42e-05	0.000147	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—MAOA—Parkinson's disease	2.42e-05	0.000147	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—HMOX1—Parkinson's disease	2.39e-05	0.000145	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—DDC—Parkinson's disease	2.38e-05	0.000145	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—CYCS—Parkinson's disease	2.38e-05	0.000145	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—ABCB1—Parkinson's disease	2.29e-05	0.00014	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP2D6—Parkinson's disease	2.26e-05	0.000138	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.25e-05	0.000137	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GSTM1—Parkinson's disease	2.23e-05	0.000136	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CTGF—Parkinson's disease	2.22e-05	0.000135	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—GPX1—Parkinson's disease	2.13e-05	0.00013	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—COMT—Parkinson's disease	2.1e-05	0.000128	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GSTP1—Parkinson's disease	2.09e-05	0.000127	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—MAOA—Parkinson's disease	2.09e-05	0.000127	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYP2E1—Parkinson's disease	2.07e-05	0.000126	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—HMOX1—Parkinson's disease	2.07e-05	0.000126	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—NQO1—Parkinson's disease	2.04e-05	0.000124	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	2.03e-05	0.000123	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—TH—Parkinson's disease	2.01e-05	0.000123	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—MAOB—Parkinson's disease	2.01e-05	0.000122	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—ABCB1—Parkinson's disease	1.98e-05	0.000121	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—MTHFR—Parkinson's disease	1.97e-05	0.00012	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—CYCS—Parkinson's disease	1.93e-05	0.000118	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GSTM1—Parkinson's disease	1.92e-05	0.000117	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—GPX1—Parkinson's disease	1.84e-05	0.000112	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—APOE—Parkinson's disease	1.83e-05	0.000111	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—COMT—Parkinson's disease	1.71e-05	0.000104	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GSTP1—Parkinson's disease	1.7e-05	0.000104	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—MTHFR—Parkinson's disease	1.7e-05	0.000104	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—MAOA—Parkinson's disease	1.7e-05	0.000103	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—HMOX1—Parkinson's disease	1.68e-05	0.000102	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—ABCB1—Parkinson's disease	1.61e-05	9.82e-05	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—APOE—Parkinson's disease	1.58e-05	9.64e-05	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GSTM1—Parkinson's disease	1.57e-05	9.53e-05	CbGpPWpGaD
Paramethadione—CYP2E1—Metabolism—INS—Parkinson's disease	1.56e-05	9.53e-05	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—GPX1—Parkinson's disease	1.5e-05	9.13e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.49e-05	9.07e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.46e-05	8.9e-05	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—MTHFR—Parkinson's disease	1.38e-05	8.43e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.36e-05	8.3e-05	CbGpPWpGaD
Paramethadione—CYP2C8—Metabolism—INS—Parkinson's disease	1.35e-05	8.23e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.35e-05	8.2e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—TH—Parkinson's disease	1.33e-05	8.08e-05	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—APOE—Parkinson's disease	1.29e-05	7.84e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.28e-05	7.76e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—COMT—Parkinson's disease	1.13e-05	6.87e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.12e-05	6.84e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.12e-05	6.83e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.11e-05	6.75e-05	CbGpPWpGaD
Paramethadione—CYP2C9—Metabolism—INS—Parkinson's disease	1.1e-05	6.7e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.06e-05	6.48e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GSTM1—Parkinson's disease	1.03e-05	6.29e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—GPX1—Parkinson's disease	9.89e-06	6.02e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—MTHFR—Parkinson's disease	9.13e-06	5.56e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—APOE—Parkinson's disease	8.5e-06	5.17e-05	CbGpPWpGaD
Paramethadione—CYP3A4—Metabolism—INS—Parkinson's disease	7.26e-06	4.42e-05	CbGpPWpGaD
